P A Ganz

Author PubWeight™ 97.98‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Polychemotherapy in advanced non small cell lung cancer: a meta-analysis. Lancet 1993 6.08
2 Fatigue in breast cancer survivors: occurrence, correlates, and impact on quality of life. J Clin Oncol 2000 4.96
3 Quality-of-life outcomes in men treated for localized prostate cancer. JAMA 1995 4.69
4 Karnofsky performance status revisited: reliability, validity, and guidelines. J Clin Oncol 1984 4.64
5 The UCLA Prostate Cancer Index: development, reliability, and validity of a health-related quality of life measure. Med Care 1998 4.34
6 Patterns of care related to age of breast cancer patients. JAMA 1987 2.92
7 Role of breast reconstructive surgery in physical and emotional outcomes among breast cancer survivors. J Natl Cancer Inst 2000 2.66
8 Quality of life of African-American and white long term breast carcinoma survivors. Cancer 1999 2.39
9 Arm edema in breast cancer patients. J Natl Cancer Inst 2001 2.35
10 Health-related quality of life and tamoxifen in breast cancer prevention: a report from the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Clin Oncol 1999 2.23
11 Perspectives on comorbidity and cancer in older patients: approaches to expand the knowledge base. J Clin Oncol 2001 2.00
12 1st International consensus guidelines for advanced breast cancer (ABC 1). Breast 2012 1.96
13 CAncer Rehabilitation Evaluation System--short form (CARES-SF). A cancer specific rehabilitation and quality of life instrument. Cancer 1991 1.82
14 Quality of life in adult survivors of lung, colon and prostate cancer. Qual Life Res 1994 1.78
15 Ductal lavage for detection of cellular atypia in women at high risk for breast cancer. J Natl Cancer Inst 2001 1.68
16 Proposed agenda for the measurement of quality-of-care outcomes in oncology practice. J Clin Oncol 1999 1.59
17 Quality of life in the first year after breast cancer surgery: rehabilitation needs and patterns of recovery. Breast Cancer Res Treat 1999 1.54
18 Psychologic distress and natural menopause: a multiethnic community study. Am J Public Health 2001 1.48
19 Tracking managed care: the importance of a cash incentive for medical director response to a survey. Am J Manag Care 2000 1.46
20 Bone mineral density and adjuvant therapy in breast cancer survivors. Breast Cancer Res Treat 2004 1.40
21 Characteristics of women at risk for psychosocial distress in the year after breast cancer. J Clin Oncol 1993 1.35
22 Quality of life in diverse groups of midlife women: assessing the influence of menopause, health status and psychosocial and demographic factors. Qual Life Res 2004 1.32
23 Missing quality of life data in cancer clinical trials: serious problems and challenges. Stat Med 1998 1.22
24 Assessing problems of cancer patients: psychometric properties of the cancer inventory of problem situations. Health Psychol 1990 1.21
25 Quality of life in patients with heart failure: do gender differences exist? Heart Lung 2001 1.20
26 Sexuality following breast cancer. J Sex Marital Ther 1999 1.15
27 Report from a National Cancer Institute (USA) workshop on quality of life assessment in cancer clinical trials. Qual Life Res 1992 1.12
28 Tamoxifen and depression: more evidence from the National Surgical Adjuvant Breast and Bowel Project's Breast Cancer Prevention (P-1) Randomized Study. J Natl Cancer Inst 2001 1.11
29 Complementary and alternative therapies among very long-term breast cancer survivors. Breast Cancer Res Treat 2008 1.07
30 Making effective use of tumor registries for cancer survivorship research. Cancer 2001 1.06
31 Living with cancer: the Cancer Inventory of Problem Situations. J Clin Psychol 1984 1.05
32 Profile of men randomized to the prostate cancer prevention trial: baseline health-related quality of life, urinary and sexual functioning, and health behaviors. J Clin Oncol 2000 1.03
33 Factors related to sexual function in postmenopausal women with a history of breast cancer. Menopause 2001 0.99
34 The psychosocial impact of cancer on the elderly: a comparison with younger patients. J Am Geriatr Soc 1985 0.99
35 Treatment options for breast cancer--beyond survival. N Engl J Med 1992 0.99
36 The association between pro-inflammatory cytokines, regional cerebral metabolism, and cognitive complaints following adjuvant chemotherapy for breast cancer. Brain Imaging Behav 2013 0.95
37 Screening by the prostate-specific antigen test: what do the patients know? J Cancer Educ 1996 0.95
38 Psychosocial concerns and quality of life in breast cancer survivors. Cancer Invest 1999 0.94
39 Assessing the needs and quality of life of patients with HIV infection: development of the HIV Overview of Problems-Evaluation System (HOPES). Qual Life Res 1992 0.93
40 The quality of life after breast cancer--solving the problem of lymphedema. N Engl J Med 1999 0.93
41 Symbiotic relationships of quality of life, health services research and other health research. Qual Life Res 1994 0.92
42 Development and validation of a physical examination scale to assess vaginal atrophy and inflammation. Climacteric 1999 0.91
43 Quality of life in advanced non-small-cell lung cancer: results of a Southwest Oncology Group randomized trial. Qual Life Res 2002 0.90
44 Effect of timed incentives on subject participation in a study of long-term breast cancer survivors: are there ethnic differences? J Natl Med Assoc 2000 0.90
45 Psychosocial issues in lung cancer patients. Cancer Treat Res 1995 0.89
46 Lung cancer in younger patients. West J Med 1980 0.87
47 Translation and validation of a quality of life instrument for Hispanic American cancer patients: methodological considerations. Qual Life Res 1995 0.85
48 Responses of patients with neoplastic diseases to influenza virus vaccine. Cancer 1978 0.85
49 Sexual functioning and intimacy in African American and white breast cancer survivors: a descriptive study. Womens Health 1998 0.84
50 Monitoring the therapy of lung cancer with alpha-1-acid glycoprotein. Cancer Res 1984 0.84
51 Sexual functioning after breast cancer: a conceptual framework for future studies. Ann Oncol 1997 0.84
52 Cognitive dysfunction following adjuvant treatment of breast cancer: a new dose-limiting toxic effect? J Natl Cancer Inst 1998 0.84
53 Toward a better understanding of health-related quality of life: a comparison of the Medical Outcomes Study HIV Health Survey (MOS-HIV) and the HIV Overview of Problems-Evaluation System (HOPES). J Acquir Immune Defic Syndr Hum Retrovirol 1998 0.83
54 Agreement between breast cancer risk estimation methods. J Natl Cancer Inst 1996 0.83
55 Quality-of-life assessment in cancer clinical trials: a status report. J Natl Cancer Inst 1992 0.82
56 Psychosocial issues in lung cancer patients (Part 1). Chest 1991 0.82
57 Organizational systems used by California capitated medical groups and independent practice associations to increase cancer screening. Cancer 2000 0.79
58 Psychosocial issues in lung cancer patients (Part 2). Chest 1991 0.79
59 Angina pectoris after doxorubicin and mitomycin therapy. Cancer Treat Rep 1983 0.78
60 Evaluation of a radioimmunoassay for alpha 1-acid glycoprotein to monitor therapy of cancer patients. J Natl Cancer Inst 1983 0.78
61 Acceptability of mobile mammography among community-dwelling older women. J Am Geriatr Soc 1997 0.77
62 Behavioral science research in the cooperative group setting: the Southwest Oncology Group experience. J Natl Cancer Inst 2000 0.77
63 Controversy about mammography screening guidelines and physician practices at a university medical center. J Cancer Educ 1998 0.77
64 Evaluation of three biochemical markers for serially monitoring the therapy of small-cell lung cancer. J Clin Oncol 1987 0.77
65 Multiple synchronous lesions of acral metastasis. West J Med 1984 0.76
66 The status of cancer rehabilitation in the late 1990s. Mayo Clin Proc 1999 0.76
67 Survival in acute leukemia in elderly patients. J Am Geriatr Soc 1991 0.75
68 Helicobacter pylori and nonulcer dyspepsia. N Engl J Med 1999 0.75
69 Prostate cancer: the price of early detection. J Clin Oncol 2001 0.75
70 Understanding patient preferences for involvement in care. Eur J Cancer 1997 0.75
71 Menopause and breast cancer: addressing the secondary health effects of adjuvant chemotherapy. J Clin Oncol 2001 0.75
72 Professional attitudes toward hospice care. Hosp J 1986 0.75
73 Amphotericin B plus combination chemotherapy for extensive non-small cell bronchogenic carcinoma. Cancer Chemother Pharmacol 1980 0.75
74 Cancer patients' attitudes toward hospice services. CA Cancer J Clin 1984 0.75
75 Quantitative and qualitative assessment of a case management program for cancer patients. Health Soc Work 1991 0.75
76 Quality of life research: clinical applications. Cancer Treat Res 1998 0.75